About this Manager, R&D Business Partner (FP&A) role at Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
The Manager, R&D Finance is a key member of Ironwood’s FP&A team, supporting the R&D, Quality, and Tech Ops organizations. This role partners closely with global business leaders to understand functional priorities and apply financial expertise to deliver insights, identify opportunities, and drive improved financial performance and strategic decision-making.
Responsibilities:
- Serve as a strategic finance partner to global R&D, Quality, and Tech Ops teams, providing decision support, financial modeling, and insights to optimize resource allocation and drive strategic priorities
- Lead end-to-end R&D financial planning and forecasting processes (AOP, quarterly forecasts, long-range plans), partnering with functional leaders to consolidate, prioritize and assess investments
- Own consolidated R&D financial reporting and performance management, including monthly close oversight, variance analysis, and preparation of executive-ready review materials
- Manage financial oversight of R&D activities, including alliance support, complex long-term contracts (e.g., clinical trials, CROs, CMOs), and review of purchase requisitions and contracts to ensure proper accounting treatment
- Ensure compliance with accounting standards and SOX requirements on accruals, reporting, and controls through partnership and coordination with Accounting teams
- Drive continuous improvement of FP&A processes, systems, and reporting; establish best practices and deliver ad hoc analysis to support broader corporate and cross-functional initiatives.
|
Requirements: |
- Bachelors or equivalent degree required; concentration in a financial discipline and/or MBA preferred
- 6+ years of progressive financial reporting, planning and analysis experience in the pharmaceutical, biotechnology or health care industry, including 3+ years prior experience supporting R&D organizations/teams
- Strong facilitation, communication and presentation skills; must have a sincere willingness and demonstrated ability to work collaboratively and partner successfully with non-Finance personnel while remaining a strong representative of/for the Finance team
- Strong proficiency in Excel and PowerPoint required, experience with SAP, Adaptive and/or other financial consolidations system strongly preferred
- Strong understanding of systems, analytical tools, financial modeling, and data management
- Strong understanding of GAAP and financial statement reporting preferred
Ironwood Pharmaceuticals is an equal opportunity employer welcoming diversity in our workforce.
Ironwood currently anticipates that the initial base salary for this position could range from between $137,000 - $155,800. The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience. Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.
#LI-Hybrid
